0001567619-21-004324.txt : 20210217
0001567619-21-004324.hdr.sgml : 20210217
20210217193120
ACCESSION NUMBER: 0001567619-21-004324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210214
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lane Michael
CENTRAL INDEX KEY: 0001740689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 21647007
MAIL ADDRESS:
STREET 1: C/O IDEXX LABORATORIES, INC.
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2021-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001740689
Lane Michael
C/O IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
Common Stock
2021-02-14
4
M
0
221
0
A
4005
D
Common Stock
2021-02-14
4
M
0
212
0
A
4217
D
Common Stock
2021-02-14
4
M
0
196
0
A
4413
D
Common Stock
2021-02-14
4
M
0
181
0
A
4594
D
Common Stock
2021-02-14
4
M
0
174
0
A
4768
D
Common Stock
2021-02-14
4
F
0
314
544.08
D
4474
D
Common Stock
2021-02-16
4
S
0
850
545
D
3624
D
Common Stock
592
I
by spouse
Non-Qualified Stock Option (right-to-buy)
544.08
2021-02-14
4
A
0
6003
A
2031-02-13
Common Stock
6003
6003
D
Incentive Stock Option (right-to-buy)
544.08
2021-02-14
4
A
0
183
A
2031-02-13
Common Stock
183
183
D
Restricted Stock Unit
2021-02-14
4
A
0
643
A
Common Stock
643
3292
D
Restricted Stock Unit
2021-02-14
4
M
0
221
D
Common Stock
221
3071
D
Restricted Stock Unit
2021-02-14
4
M
0
212
D
Common Stock
212
2859
D
Restricted Stock Unit
2021-02-14
4
M
0
196
D
Common Stock
196
2663
D
Restricted Stock Unit
2021-02-14
4
M
0
181
D
Common Stock
181
2482
D
Restricted Stock Unit
2021-02-14
4
M
0
174
D
Common Stock
174
2308
D
Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
2021-02-17